Arthrogryposis multiplex congenita-6 is a rare genetic condition that causes multiple joint contractures present at birth. People with Arthrogryposis multiplex congenita-6 often have stiff elbows, wrists, hips, knees, or feet and may have muscle weakness. Signs are lifelong but can improve with early therapy, and not everyone will have the same experience. Treatment focuses on physical and occupational therapy, splints or casts, and sometimes surgery, and many children benefit from early intervention. Most live into adulthood, but outlook depends on how many joints are involved and whether other body systems are affected.
Overview
Arthrogryposis multiplex congenita-6Symptoms
Arthrogryposis multiplex congenita-6 features stiff joints present at birth, with limited movement in the shoulders, elbows, wrists, hips, knees, and feet (often clubfoot). Early signs of Arthrogryposis multiplex congenita-6 can include muscle weakness, limb positioning difficulties, and delayed motor milestones.
Outlook and prognosis
Many living with Arthrogryposis multiplex congenita-6 can gain meaningful independence with early, tailored therapy and adaptive equipment. Joint tightness often remains but may stabilize after childhood. Long-term outlook varies by muscle strength, joint involvement, and any breathing or feeding challenges.
Causes and risk factors
Arthrogryposis multiplex congenita-6 results from a disease‑causing change in a gene, present from conception. It may be inherited or occur as a new mutation. Risk rises with carrier status or family history; pregnancy factors affecting fetal movement can modify severity.
Genetic influences
Genetics play a major role in Arthrogryposis multiplex congenita-6, which is usually caused by pathogenic variants in single genes affecting fetal muscle and nerve function. Inherited patterns vary, including autosomal recessive and dominant forms, and rare de novo variants occur.
Diagnosis
Doctors suspect Arthrogryposis multiplex congenita-6 from clinical features at birth, supported by imaging. Confirmation usually relies on genetic testing. The genetic diagnosis of Arthrogryposis multiplex congenita-6 may guide family testing and counseling.
Treatment and drugs
Treatment for Arthrogryposis multiplex congenita-6 focuses on function, comfort, and independence. Care often includes early, tailored physical and occupational therapy, splints or serial casting, pain management, and orthopedic procedures when needed, with adaptive devices to support daily activities.
Symptoms
Arthrogryposis multiplex congenita-6 mainly affects how joints move from birth. In medical terms, this is a congenital joint contracture condition; in everyday life, it shows up as joints that don’t fully bend or straighten. Early features of Arthrogryposis multiplex congenita-6 often include stiff elbows, wrists, hips, knees, and feet that are hard to position. The exact mix of joints and how much they’re affected can differ widely.
Stiff or fixed positions in multiple joints are present at birth. In Arthrogryposis multiplex congenita-6, these can involve elbows, wrists, knees, hips, and fingers. Everyday motions like stretching an arm or fully straightening a knee may be limited.
Range of motion is smaller across affected joints. Activities like getting up from the floor or using stairs can take extra time.
Feet may point downward or inward (clubfoot). In Arthrogryposis multiplex congenita-6, this can change how a child stands and learns to walk. Shoe fit and balance may be tricky.
Fingers may be curved or tightly flexed. Gripping, writing, or opening containers can be harder. Fine motor tasks at school or work may take extra time.
How people usually first notice Arthrogryposis multiplex congenita-6?
Parents and doctors often first notice arthrogryposis multiplex congenita-6 at birth when a baby has joints that don’t move well, with arms or legs held in fixed positions and tight, web-like soft tissue limiting motion. Early checkups may also pick up features like clubfoot, a small jaw or chin, or muscle weakness, and sometimes reduced movement was observed on late-pregnancy ultrasound, which can hint at the first signs of arthrogryposis multiplex congenita-6. As the baby grows, challenges with feeding, breathing, or delayed motor milestones can draw attention to how arthrogryposis multiplex congenita-6 is first noticed and prompt genetic and neurologic evaluation.
Types of Arthrogryposis multiplex congenita-6
Arthrogryposis multiplex congenita-6 is a genetic condition with recognized clinical variants linked to different gene changes. These variants can affect muscles and nerves differently, which leads to variation in joint stiffness, movement, breathing strength, and feeding. People may notice different sets of symptoms depending on their situation. Understanding the main variants can help make sense of the types of Arthrogryposis multiplex congenita-6 you might read about in reports or genetic results.
Classic distal form
Stiffness mainly affects hands and feet. Walking and fine hand use may be limited, but breathing and swallowing can be less affected. Early symptoms of Arthrogryposis multiplex congenita-6 often show up in infancy.
Proximal-predominant form
Hips and shoulders are more affected than the hands and feet. Lifting arms, rolling, or standing can be delayed because larger muscle groups are weaker. Daily tasks like dressing may take longer.
Neurogenic variant
Weakness stems mainly from nerve-signal problems to the muscles. This variant can include reduced reflexes and sometimes breathing or feeding challenges in newborns. Some may need respiratory support during illnesses.
Myopathic variant
Muscle fiber involvement is the main driver of stiffness and weakness. People may have fatigue with activity and slower motor progress. Muscle enzymes or studies can show a primary muscle pattern.
Respiratory-involved variant
Chest wall stiffness and weaker breathing muscles are prominent. Babies may have low energy, shallow breathing, or trouble clearing secretions. Close monitoring during sleep and infections is common.
Feeding-impact variant
Jaw and throat muscle stiffness lead to poor latch, slow feeding, or choking episodes. Weight gain can lag without feeding strategies or tube support. Swallow studies often guide safe feeding plans.
What genetics can tell you about symptoms
Some people with arthrogryposis multiplex congenita-6 (AMC6) have mutations in the ECEL1 gene that disrupt nerve signals to muscles, leading to stiff joints at birth, limited range of motion, and facial differences like droopy eyelids. Variants in other AMC-related genes can shift which joints are tight, how severe contractures are, and whether breathing or feeding troubles appear.
Causes and risk factors
Arthrogryposis multiplex congenita-6 usually results from a single-gene change that is present from birth. The gene change can be inherited from parents, or it can arise for the first time in the child. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Family history is a key risk factor for Arthrogryposis multiplex congenita-6, and having close relatives with similar features raises the chance. Pregnancy factors that limit fetal movement, like low amniotic fluid, some infections, or uterine crowding, may shape severity but do not cause the genetic condition.
Environmental and biological risk factors
Arthrogryposis multiplex congenita-6 is present at birth, so understanding what increases the chance during pregnancy can help you talk with your care team. Doctors often group risks into internal (biological) and external (environmental). While early symptoms of Arthrogryposis multiplex congenita-6 are seen at delivery, many influences that raise risk act much earlier in the womb. Below are factors linked to reduced fetal movement and joint positioning that can make this condition more likely.
When a baby moves less in the womb, joints can stiffen and lock, raising the chance of Arthrogryposis multiplex congenita-6. Limited motion may stem from intrinsic nerve or muscle differences or from tight positioning. Longer periods of low movement increase the risk of fixed contractures.
Too little fluid reduces the cushion around the baby, making free movement harder. This prolonged pressure on joints can lead to stiffness and contractures. Low fluid can follow early membrane leakage or other pregnancy complications.
Twins, fibroids, or a differently shaped uterus can limit space for movement. Staying in one position for long stretches can restrict joint motion and contribute to Arthrogryposis multiplex congenita-6. The effect grows when crowding lasts through key stages of joint development.
If the placenta delivers less oxygen and nutrients, babies may be weaker and move less. Reduced movement increases the likelihood of the joint contractures seen in Arthrogryposis multiplex congenita-6. This pattern often coexists with slower fetal growth.
Genetic risk factors
Arthrogryposis multiplex congenita-6 (AMC-6) is typically caused by harmful changes in a single gene that guides how nerves and muscles form before birth. In many families, parents are healthy carriers and a child is affected when both copies of the gene carry a change. Some risk factors are inherited through our genes. Genetic testing for Arthrogryposis multiplex congenita-6 can confirm the cause and clarify the chance of recurrence in a family.
Recessive inheritance: AMC-6 most often follows an autosomal recessive pattern, with one changed copy inherited from each parent. Each pregnancy then has a 25% (1 in 4) chance to be affected.
Carrier parents: Parents are usually symptom-free carriers who can pass the gene change to their children. Carrier testing can clarify each parent’s status.
Causative gene change: A disease-causing change (variant) in the AMC-6–related gene disrupts early nerve–muscle connections. Reduced movement in the womb leads to joint contractures seen at birth. Finding the exact variant can inform family planning.
Family history: Having a prior child with AMC-6 or relatives with similar findings indicates a higher likelihood of carrier status in the family. This helps guide who else may benefit from testing.
Shared ancestry: When parents are related or come from the same small community, they are more likely to share the same rare gene change. This raises the chance of having a child with AMC-6.
Variant differences: Different changes in the same gene can lead to milder or more severe features, even within one family. People with the same risk factor can have very different experiences.
Founder variants: In certain populations, a single ancestral gene change can make AMC-6 more frequent. Knowledge of local founder variants can speed targeted testing.
Genetic testing: A lab analysis can look for the AMC-6–related gene changes to confirm the diagnosis. Confirming the variant refines recurrence risk and enables carrier testing for relatives.
Lifestyle risk factors
Arthrogryposis multiplex congenita-6 is a congenital condition; lifestyle habits do not cause it. However, daily routines can influence joint stiffness, mobility, pain, bone health, and complications over time. Here’s how lifestyle affects Arthrogryposis multiplex congenita-6 and the lifestyle risk factors for Arthrogryposis multiplex congenita-6.
Long periods of inactivity can increase joint stiffness and reduce range of motion in AMC-6. Gentle, regular movement helps preserve flexibility and function.
Inconsistent stretching or splint wear can allow contractures to tighten more. Adhering to daily therapy supports mobility and may delay the need for interventions.
Extra weight adds strain to already-limited joints and makes transfers and mobility aids harder to use. Weight management can reduce fatigue and improve participation in therapy.
Insufficient protein can hinder muscle maintenance and recovery after orthopedic procedures. Adequate protein supports strength gains from therapy.
Risk prevention
Arthrogryposis multiplex congenita-6 is a genetic condition present from birth, so there’s no way to fully prevent it. Prevention focuses on informed family planning and on reducing complications before and after birth so children have the best possible function and comfort. Some prevention is universal, others are tailored to people with specific risks. For families with a history of this condition, a genetics team can outline options to lower recurrence risk and support early care.
A genetics professional can explain inheritance patterns, recurrence risk, and testing options. This helps you make informed choices for future pregnancies.
Relatives planning a pregnancy can consider carrier screening to see if they carry the gene change. Results can guide next steps, including reproductive planning.
During pregnancy, targeted genetic testing and detailed ultrasound can check for signs linked to Arthrogryposis multiplex congenita-6. Knowing early supports delivery planning and newborn care.
With IVF, preimplantation genetic testing (PGT) can identify embryos without the familial gene change. This can reduce the chance of having another child with the condition.
Transmission
Arthrogryposis multiplex congenita-6 is a genetic condition, not an infection, so it isn’t spread through touch, coughing, or everyday contact. In most families, arthrogryposis multiplex congenita-6 is inherited in an autosomal recessive pattern, meaning both parents are usually healthy carriers who each pass on one altered copy of the gene. When two carriers have a child, each pregnancy has a 25% chance the child will have the condition, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy. A genetics professional can explain how arthrogryposis multiplex congenita-6 is inherited in your family and discuss the genetic transmission of arthrogryposis multiplex congenita-6 and chances for future children.
When to test your genes
Consider genetic testing if arthrogryposis is present at birth, if joint contractures recur in your family, or if pregnancy ultrasound shows reduced fetal movement or limb positioning concerns. Testing can confirm the AMC6 subtype, guide tailored therapies and mobility planning, and inform anesthesia and surgical risks. It also clarifies recurrence risk for future pregnancies and enables carrier testing for relatives.
Diagnosis
For many, the first step comes when everyday activities start feeling harder—but with Arthrogryposis multiplex congenita-6, the first clues are often seen at birth or even before birth on ultrasound. Doctors typically recognize a pattern of tight joints and limited movement, then confirm the subtype with targeted testing. Early and accurate diagnosis can help you plan ahead with confidence. The diagnosis of Arthrogryposis multiplex congenita-6 usually combines a careful exam with imaging and genetic tests.
Doctors look for multiple joint contractures, limited range of motion, and muscle tone differences. These clinical features help distinguish this condition from other causes of stiff joints.
Imaging during pregnancy may show reduced fetal movement and fixed joint positions. These findings can prompt planning for specialized care at delivery.
A detailed family and health history can help identify inherited patterns or similar features in relatives. Family history is often a key part of the diagnostic conversation.
A blood or saliva test can look for changes in a gene linked to this specific subtype. Finding a causative variant can confirm the genetic diagnosis of Arthrogryposis multiplex congenita-6 and guide family planning.
Stages of Arthrogryposis multiplex congenita-6
Arthrogryposis multiplex congenita-6 does not have defined progression stages. This condition is present from birth and usually does not worsen over time, though abilities may change with growth, therapy, or surgery. Doctors often recognize it by fixed joints in several areas and limited movement; early symptoms of Arthrogryposis multiplex congenita-6 are usually noticed at birth or on a prenatal ultrasound. Different tests may be suggested to help confirm the cause and guide care, such as imaging of joints, simple movement checks, electrical tests of nerves and muscles, and genetic testing to pinpoint the subtype.
Outlook and prognosis
Daily routines often adapt as families learn which positions are most comfortable, which braces help, and how to pace therapy sessions for Arthrogryposis multiplex congenita-6. The outlook is not the same for everyone, but most children with AMC-6 can make steady gains in mobility and self-care with early and consistent physical and occupational therapy. Doctors call this the prognosis—a medical word for likely outcomes. Many people find that symptoms like joint stiffness are most noticeable in the first years of life and then stabilize as growth continues.
Some people experience significant contractures in multiple joints, while others notice more limited areas that respond well to splints and stretching. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. When breathing muscles or feeding are affected, closer monitoring is needed in infancy; if those systems are stable, life expectancy is usually near typical, and mortality is generally tied to early complications rather than AMC-6 itself. Over time, most people benefit from targeted surgeries to release tight tendons, followed by therapy to maintain range of motion and build strength.
Looking at the long-term picture can be helpful. With ongoing care, many people maintain independence in school, work, and daily activities, though assistive devices or modified tools may be part of the plan. Genetic testing can sometimes provide more insight into prognosis, especially when different gene changes within AMC-6 families lead to milder or more complex needs. Talk with your doctor about what your personal outlook might look like, and ask about early symptoms of Arthrogryposis multiplex congenita-6 that deserve prompt attention, like feeding difficulties, breathing concerns, or rapidly worsening joint stiffness.
Long-term effects
Daily life often centers on how well joints move and what positions feel comfortable from morning to night. Many early symptoms of Arthrogryposis multiplex congenita-6 are present at birth as fixed joint positions, and these typically evolve into ongoing features that shape mobility and independence. Long-term effects vary widely, and needs can change from childhood through adulthood. Over time, daily routines may shift as people find efficient ways to move, work, and take part in school or community life.
Fixed joint positions in the shoulders, elbows, wrists, hips, knees, or ankles often continue across the lifespan. These contractures can loosen or shift with growth but usually do not fully resolve.
Stiff joints can restrict how far a limb can bend or straighten. This can affect tasks like dressing, writing, or reaching overhead.
Walking may be possible but effortful, or mobility may rely on braces, crutches, or wheelchairs. Distances and uneven ground can be challenging over time.
Muscles around affected joints can be smaller or weaker. This may lead to fatigue with repeated tasks or long days.
How is it to live with Arthrogryposis multiplex congenita-6?
Living with Arthrogryposis multiplex congenita-6 often means planning around joints that are stiff from birth, using braces, splints, or mobility devices, and building strength with regular physical and occupational therapy. Daily tasks like dressing, reaching, or writing can take more time and creativity, but many find workarounds—adaptive tools, modified environments, and routines that conserve energy and protect joints. Families, caregivers, and classmates or coworkers may need to adjust expectations and offer practical help, yet they also become partners in celebrating milestones that others might take for granted. With coordinated care and accessible settings, many grow into confident problem-solvers who participate fully at home, school, and work.
Treatment and drugs
Treatment for Arthrogryposis multiplex congenita-6 focuses on improving movement, comfort, and independence rather than “curing” the condition. Care usually starts early with gentle, regular physical and occupational therapy to stretch tight joints, build strength, and support everyday tasks like sitting, standing, or grasping; splints, braces, and custom shoes can help hold joints in better positions. Orthopedic surgery may be considered to release tight tissues, correct foot or hip position, or improve elbow and knee function, and a doctor may adjust your dose to balance benefits and side effects if pain medicines or muscle relaxants are used short term around procedures or therapy. Assistive devices—such as walkers, wheelchairs, adapted utensils, or communication tools—are matched to age and goals, and many find that school-based services and rehabilitation programs make daily routines easier. Supportive care can make a real difference in how you feel day to day, and treatment plans often combine several approaches that are reviewed over time as needs change.
Non-drug treatment
Living with Arthrogryposis multiplex congenita-6 often means working around tight joints, limited range of motion, and day-to-day tasks that take extra effort. Early, steady therapy can build strength, protect joints, and make moving, feeding, and dressing easier over time. Non-drug treatments often lay the foundation for function, independence, and comfort across childhood and into adult life. Care plans are tailored, since joint patterns and muscle strength can vary widely from person to person.
Gentle, frequent stretching and range-of-motion work helps keep joints from getting stiffer. Therapists also build core and limb strength to support posture and balance. Home exercise plans keep progress going between visits.
Training focuses on everyday skills like dressing, feeding, and writing, using simple techniques to make tasks easier. Therapists suggest tools and ways to set up the home or school for better independence.
Daily, structured stretches help maintain joint motion and reduce contractures over time. Families learn safe techniques to prevent pain or injury.
Custom splints hold joints in a better position and can be worn at night or during the day. Serial casting gently repositions a tight joint in small steps over several weeks.
Your genes may have an impact on how drugs work for you
For many living with Arthrogryposis multiplex congenita-6, genes can affect how the body handles medicines, changing how quickly a drug is broken down or how strongly it works. This means doses or drug choices may be adjusted to balance benefit and side effects.
Pharmacological treatments
Arthrogryposis multiplex congenita-6 (AMC6) doesn’t have a medicine that reverses joint contractures, but medicines can ease pain, stiffness, and related issues so daily care and therapy go more smoothly. Drugs that target symptoms directly are called symptomatic treatments. Most medications for Arthrogryposis multiplex congenita-6 are used alongside physical therapy, splinting, and surgery. Your team will tailor choices to age, comfort, breathing or feeding needs, and how active you or your child are.
Acetaminophen/paracetamol and NSAIDs like ibuprofen or naproxen can reduce everyday pain and soreness in AMC6. They may be used before therapy sessions or after procedures to improve comfort. NSAIDs can irritate the stomach, so take with food unless told otherwise.
Oral agents such as baclofen or tizanidine may ease muscle tightness that limits stretching in Arthrogryposis multiplex congenita-6. Benefits vary, and sleepiness or low blood pressure can occur. Your clinician may adjust the dose slowly to balance relief and side effects.
Botulinum toxin A injected into selected muscles can temporarily lessen the pull on a joint in AMC6. This can make splinting or serial casting more effective. Effects typically last about 3–4 months before reassessment.
Gabapentin or pregabalin may help if nerve-type pain appears after surgery or from pressure areas. These do not change joint contractures but can reduce burning or shooting pain. Dizziness or sleepiness are possible side effects.
Genetic influences
In arthrogryposis multiplex congenita-6, research points to changes in one gene as the underlying cause. These changes can alter how muscles, nerves, and joints develop and move before birth, which leads to the stiff joints seen at delivery. DNA testing can sometimes identify these changes. Some families have more than one affected child, while in others the change appears for the first time in the baby; inheritance patterns can differ between families. Even when the same gene is involved, the condition can look different from person to person, with variation in which joints are tight and how much support is needed over time. Finding the genetic cause of arthrogryposis multiplex congenita-6 can help tailor care, clarify chances in a future pregnancy, and prepare families for early symptoms of arthrogryposis multiplex congenita-6.
Is Arthrogryposis multiplex congenita-6 genetic?
Genetics play a major role in Arthrogryposis multiplex congenita-6, which is usually caused by pathogenic variants in single genes affecting fetal muscle and nerve function. Inherited patterns vary, including autosomal recessive and dominant forms, and rare de novo variants occur.
Pharmacogenetics—how genetics influence drug effects
People living with Arthrogryposis multiplex congenita-6 (AMC6) often need surgeries and ongoing therapies, so choices about anesthesia and pain medicines matter day to day. The same genetic change that causes AMC6 can also influence how muscles and nerves respond to anesthesia, which may change how safe or effective certain drugs are in the operating room. In some arthrogryposis gene patterns, there’s a higher risk of malignant hyperthermia with specific gas anesthetics and some fast‑acting muscle relaxants, so teams may choose non‑triggering options and monitor closely. After procedures, common pain medicines are processed differently from person to person; for example, genes that affect how the body activates codeine or tramadol can lead to too little pain relief or more side effects, guiding doctors toward alternatives.
Genetic testing can sometimes identify how your body is likely to handle certain medicines or anesthesia. While there are no gene‑targeted drugs for Arthrogryposis multiplex congenita-6 yet, pharmacogenetic testing in Arthrogryposis multiplex congenita-6 may help personalize anesthesia plans, fine‑tune dosing, and lower the chance of medication side effects.
Interactions with other conditions
For people with Arthrogryposis multiplex congenita-6, joint contractures and reduced mobility can interact with other health conditions in very practical ways. Day-to-day, it can feel like one health issue amplifies the other. Breathing problems such as recurrent chest infections or asthma may be harder to manage if chest movement is limited, and even mild colds can temporarily reduce stamina. If scoliosis or a small, stiff chest is also present, lung capacity can be lower, so respiratory illnesses sometimes hit harder. Feeding and swallowing challenges may overlap with reflux, which can raise the risk of food or liquid going “down the wrong way” and lead to pneumonia. Because early symptoms of Arthrogryposis multiplex congenita-6 can overlap with other neuromuscular conditions, coordinated care across specialties helps tailor therapy and avoid medications that might worsen muscle weakness or breathing.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies born with very stiff joints and limited movement. Midwives and doctors noted newborns who kept their arms straight or their feet turned in, and families often remembered relatives who had similar tightness from birth. These early observations captured the day-to-day reality—difficulty bending elbows to dress, or ankles so rigid that first steps came late—even when the cause remained unclear.
From early theories to modern research, the story of Arthrogryposis multiplex congenita-6 has unfolded step by step. At first, all forms of arthrogryposis were grouped together because they looked alike: multiple joints fixed in place at birth. As careful case reports accumulated, differences emerged in which joints were affected, how muscles looked and felt, and whether nerves or the brain seemed involved. Doctors realized there were many subtypes, each with its own pattern and course.
In recent decades, advances in genetics helped sort these patterns more precisely. Researchers found that some families carried changes in single genes that influence how muscles, nerves, or the supporting structure of joints develop before birth. For a subset now labeled Arthrogryposis multiplex congenita-6, the shared features and inheritance pointed to a distinct cause. Genetic testing then confirmed that a specific gene change could explain the consistent findings seen across different families.
Over time, descriptions became clearer about what makes this subtype different from others: which joints tend to be most affected, how muscle tone appears, and whether growth and learning are otherwise typical. This matters in everyday life, because it guides early support—like casting, splints, and physical therapy—and helps families understand what to expect as a child grows.
These historical steps shaped today’s care. Early accounts taught clinicians to look closely at patterns across the whole body, not just a single tight joint. Later, family histories and “repeat” patterns across generations highlighted when a genetic explanation was likely. Finally, modern gene studies tied the clinical picture to a molecular cause, allowing more accurate diagnosis and counseling.
Not every early description was complete, yet together they built the foundation of today’s knowledge. Knowing this history explains why the umbrella term “arthrogryposis” is still used in clinics, while more exact labels like Arthrogryposis multiplex congenita-6 help tailor care and inform testing. It also reminds us that while the name is specific, the goal remains practical: to support movement, comfort, and independence for people living with this condition.